The market for 3D printing medical devices is expected to grow at a CAGR of 16.3 percent from USD 2.4 billion in 2021 to USD 5.1 billion in 2026. Increasing public-private funding for 3D printing activities, high prevalence of dental and orthopaedic diseases, ease of developing customised medical products using 3D printing, expanding applications of 3D printing in the healthcare industry, availability of advanced 3D printing materials for dental and medical applications, and rising demand for 3D-printed products in the cosmetics and pharmaceutical industries.
As a result of the pandemic, access to clients to sell and implement 3D Printing Medical Devices decreased in March 2020 and during the second quarter of 2020, as hospitals focused solely on the COVID-19 epidemic. The epidemic has resulted in a huge surge in ventilator demand. Manufacturing facility closures due to lockdowns and interrupted supply chains had a minor impact on the geographical growth of the 3D Printing Medical Devices market in 2020. Established vendors like Stratasys Ltd backed up the increasing demand and helped to alleviate crucial shortages of nasopharyngeal swabs and face shields. The company created field-ready, individually packaged pamphlets.
A huge surge in public-private funding to assist various efforts in the 3D printing industry has occurred in recent years. Such research and funding initiatives are projected to accelerate the development of 3D printing products and technologies, propelling the 3D printing medical devices market forward.
The absence of a competent workforce is one of the most significant impediments to the adoption of additive manufacturing or 3D printing. There is a relatively limited pool of people who are familiar with 3D printing procedures, which is exacerbated by the quick rate of technological and material change in the 3D printing medical devices sector.
There are few training programmes available for additive manufacturing, and there is a significant gap between academic research and business applications that is difficult to cross. In additive manufacturing, the lack of a workforce with a thorough understanding of the design process and production cycle has an impact on the final quality.
The digitization of dentistry and medical procedures has advanced immensely over the years, with the intention of improving the clinical workflow through the incorporation of technology. The industry is experiencing a shift from traditional to digital dentistry and surgeries. Direct digital manufacturing involves the application of computer-controlled processes for developing a physical object directly from a digital design. With advancements in 3D printing, direct digital manufacturing is becoming a widely used technology as compared to traditional manufacturing techniques. It offers a unique set of advantages as it eliminates the investment in tooling, reduces the lag time between designin
Small and medium-sized end users may find it unfeasible to establish 3D printing facilities due to financial constraints. This is a key challenge in the market. The cost of a high-resolution 3D printer is around USD 40,000–100,000, while the cost of a 3D printer used for printing craniomaxillofacial implants is approximately USD 3,500–4,000; ROI for these devices can only be met after 1–2 years. This also makes it difficult for healthcare facilities dependent on federal funding (for whom securing funds in itself is a time-consuming process) to instal and use such equipment. Due to this financial aspect, many smaller dental and orthopaedic clinics may choose to outsource production to service
Comments
Post a Comment